1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

What's up with Auxiliums board?

Discussion in 'Atley Pharmaceuticals' started by Anonymous, Apr 21, 2013 at 2:25 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Are you guys even a real company?
  2. Anonymous

    Anonymous Guest

    Yes, but I heard that place has MAJOR issues
  3. Anonymous

    Anonymous Guest

    yes, google the new blogger who is pointing out a severely damaged male organ after participating on a clinical trial for a medicine they are trying to get FDA approval to treat physical problems with this male organ. the pictures on the bloggers sight are HORRIFIC AND this company keeps removing all threads in an apparent attempt to hide concerns over deformed the man's main vein. sad. Sick!